CLSI M100 Webinar
Updates in Antimicrobial Susceptibility Testing
Join CLSI for a webinar on the latest updates in Antimicrobial Susceptibility Testing (AST) with the release of the new CLSI M100 Ed36 (Jan 2026). This webinar provides current recommendations for AST in diagnostic settings to ensure your laboratory is prepared to:
- Identify which drugs to test.
- Determine that your test results are reliable.
- Confirm testing results that are unusual or uncommon.
Gain insights on new breakpoints and how to successfully implement the new guidance into your laboratory practices, including a discussion of key changes in this edition, such as:
- Recommendations for testing aztreonam-avibactam, a new cutting-edge agent for treating infections caused by multi-drug resistant Enterobacterales.
- Expanded guidance for testing several agents against Acinetobacter spp., including multi-drug-resistant isolates.
- Updated multifacility antibiogram for anaerobic bacteria. This resource remains a valuable tool for understanding the susceptibility trends of anaerobic species.
Looking to register a group for this webinar? Find more information about group registration here.
Date: 25 February 2026 | 1:00 PM ET
{{FormatPrice(currentPrice)}}
Free
{{FormatPrice(nonMemberPrice)}} List PriceLearning Objectives
Upon completion of this session, participants will be able to:
- Identify the major changes found in the updated 36th edition of the CLSI M100 document.
- Design a strategy for implementing the new standard into laboratory practices.
- Develop a communication strategy for informing clinical personnel of significant AST and reporting changes.
Intermediate: Refresher course. Some basic knowledge required, for the experienced staff technologist with some years of experience.
CLSI is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E® Program.
CLSI is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.
Learning Objectives
Upon completion of this session, participants will be able to:
- Identify the major changes found in the updated 36th edition of the CLSI M100 document.
- Design a strategy for implementing the new standard into laboratory practices.
- Develop a communication strategy for informing clinical personnel of significant AST and reporting changes.
Intermediate: Refresher course. Some basic knowledge required, for the experienced staff technologist with some years of experience.
CLSI is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E® Program.
CLSI is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.